Atlas Trials

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT03692663 · UNKNOWN

Trial details

NCT number
NCT03692663
Sponsor
Allife Medical Science and Technology Co., Ltd.
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2018-12-01
Primary completion
2023-06-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.